Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Breast > FUR801b
  • Cores:
    80
    CASES:
    80
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    10
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR801b
$345.00
Add To Collect

Description: Endometrial disease spectrum (endometrial cancer progression) tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing UT801a

Details: Endometrial carcinoma tissue microarray, 25 cases of endometrioid adenocarcinoma, 4 adenosquamous carcinoma, 1 squamous cell carcinoma, 6 metastatic endometrioid carcinoma, 3 polyp, 20 endometrial hyperplasia, 5 endometritis, 16 endometrium tissue, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • NAT(*)
  • Normal(*)
  • Metastasis(*)
  • Hyperplasia(*)
  • Inflammation(*)
  • Malignant(I)
  • Malignant(IB)
  • Malignant(IC)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIC)
  • _ph
TISSUE ARRAYS
FUR801b
1
2
3
4
5
6
7
8
9
10
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Abd
Col
Lym
Pel
Ova
Abd
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
H
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
_ph
FUR801b
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 60 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
A2
2 73 F Uterus Endometrioid adenocarcinoma * T1CN0M0 IC Malignant
A3
3 62 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
A4
4 49 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
A5
5 43 F Uterus Endometrioid adenocarcinoma 1 T1N0M0 I Malignant
A6
6 51 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
A7
7 62 F Uterus Endometrioid adenocarcinoma 1 1BN0M0 IB Malignant
A8
8 62 F Uterus Endometrioid adenocarcinoma * T1CN1M0 IIIC Malignant
A9
9 61 F Uterus Endometrioid adenocarcinoma 1 T1CN0M0 IC Malignant
A10
10 63 F Uterus Endometrioid adenocarcinoma 2 T1CN0M0 IC Malignant
B1
11 61 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
B2
12 51 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
B3
13 44 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
B4
14 56 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant
B5
15 60 F Uterus Endometrioid adenocarcinoma 2 T1BN0M0 IB Malignant
B6
16 58 F Uterus Endometrioid adenocarcinoma * T1BN0M0 IB Malignant
B7
17 70 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
B8
18 63 F Uterus Endometrioid adenocarcinoma 1 T3AN0M0 IIIA Malignant
B9
19 58 F Uterus Endometrioid adenocarcinoma 1 T1BN0M0 IB Malignant
B10
20 56 F Uterus Endometrioid adenocarcinoma 2 T1BN0M0 IB Malignant
C1
21 52 F Uterus Endometrioid adenocarcinoma 2 T1BN0M0 IB Malignant
C2
22 54 F Uterus Endometrioid adenocarcinoma 2 T1N0M0 I Malignant
C3
23 54 F Uterus Endometrioid adenocarcinoma 2 T1CN0M0 IC Malignant
C4
24 63 F Uterus Endometrioid adenocarcinoma 3 T1CN0M0 IC Malignant
C5
25 44 F Uterus Endometrioid adenocarcinoma 3 T1BN0M0 IB Malignant
C6
26 55 F Uterus Adenosquamous carcinoma * T1BN0M0 IB Malignant
C7
27 54 F Uterus Adenosquamous carcinoma * T2BN0M0 IIB Malignant
C8
28 56 F Uterus Adenosquamous carcinoma * T1BN0M0 IB Malignant
C9
29 73 F Uterus Adenosquamous carcinoma * T1BN0M0 IB Malignant
C10
30 60 F Uterus Squamous cell carcinoma * T2N0M0 II Malignant
D1
31 39 F Abdominal cavity Metastatic endometrioid adenocarcinoma * * * Metastasis
D2
32 76 F Colon Metastatic endometrioid adenocarcinoma * * * Metastasis
D3
33 45 F Lymph node Metastatic endometrioid adenocarcinoma of pelvic cavity * * * Metastasis
D4
34 69 F Pelvic cavity Metastatic endometrioid adenocarcinoma * * * Metastasis
D5
35 51 F Ovary Metastatic endometrioid adenocarcinoma * * * Metastasis
D6
36 40 F Abdominal cavity Metastatic endometrial adenosquamous carcinoma * * * Metastasis
D7
37 37 F Uterus Endometrial polyp * * * Hyperplasia
D8
38 57 F Uterus Endometrial polyp * * * Hyperplasia
D9
39 69 F Uterus Endometrial polyp * * * Hyperplasia
D10
40 47 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E1
41 83 F Uterus Severe atypical hyperplasia of endometrium * * * Hyperplasia
E2
42 52 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E3
43 65 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E4
44 40 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E5
45 43 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E6
46 37 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E7
47 49 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E8
48 70 F Uterus Moderate atypical hyperplasia of endometrium * * * Hyperplasia
E9
49 51 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
E10
50 62 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
F1
51 52 F Uterus Mild*moderate atypical hyperplasia of endometrium * * * Hyperplasia
F2
52 69 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
F3
53 50 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
F4
54 64 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
F5
55 48 F Uterus Endometrial simple hyperplasia * * * Hyperplasia
F6
56 50 F Uterus Endometrial adenomatous hyperplasia * * * Hyperplasia
F7
57 69 F Uterus Mild*moderate atypical hyperplasia of endometrium * * * Hyperplasia
F8
58 44 F Uterus Moderate atypical hyperplasia of endometrium * * * Hyperplasia
F9
59 48 F Uterus Mild*moderate atypical hyperplasia of endometrium * * * Hyperplasia
F10
60 48 F Uterus Chronic endometritis * * * Inflammation
G1
61 60 F Uterus Chronic endometritis * * * Inflammation
G2
62 63 F Uterus Chronic endometritis * * * Inflammation
G3
63 65 F Uterus Chronic endometritis * * * Inflammation
G4
64 51 F Uterus Chronic endometritis * * * Inflammation
G5
65 41 F Uterus Adjacent normal endometrium tissue (secretory) * * * NAT
G6
66 41 F Uterus Adjacent normal endometrium tissue (secretory) * * * NAT
G7
67 37 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
G8
68 40 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
G9
69 53 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
G10
70 61 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
H1
71 41 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
H2
72 43 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
H3
73 44 F Uterus Adjacent normal endometrium tissue (secretory) * * * NAT
H4
74 34 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
H5
75 63 F Uterus Adjacent normal endometrium tissue * * * NAT
H6
76 42 F Uterus Adjacent normal endometrium tissue (proliferative*phase) * * * NAT
H7
77 45 F Uterus Adjacent endometritis tissue * * * NAT
H8
78 40 F Uterus Normal endometrium tissue (proliferative*phase) * * * Normal
H9
79 21 F Uterus Normal endometrium tissue (proliferative*phase) * * * Normal
H10
80 21 F Uterus Normal endometrium tissue (secretory) * * * Normal
_pheochromocytoma_
Find overlapping cases with this tissue array:
  • FUR801b
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:04
    Download
1.240890s